AFT — AFT Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapHigh Flyer

Annual balance sheet for AFT Pharmaceuticals, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	7.94	4.75	12	11.1	10.2
Net Total Accounts Receivable
Net Total Receivables	29.9	39.6	41	43.2	58.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	77.5	94.6	106	108	149
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.36	3.37	3.82	3.25	3.36
Net Intangible Assets
Other Long Term Assets
Total Assets	127	148	165	170	217
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	29.1	39.8	46.1	43.3	66.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities	65	74.8	77.5	72.2	107
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	62.3	73.3	87.8	97.6	110
Total Liabilities & Shareholders' Equity	127	148	165	170	217
Total Common Shares Outstanding